Inclusion complexation of amide-typed local anaesthetics with ß-cyclodextrin and its derivatives. I. Physicochemical characterization

International Journal of Pharmaceutics

Volumn 131, Issue 2, 1996, Pages 219-228

  Dollo, Gilles ^a   Le Corre, Pascal ^a   Chevanne, Francois ^a   Le Verge, Roger ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

13C NMR; 1H NMR; Cyclodextrins; DSC; Inclusion compound; IR; Local anaesthetics

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN; BUPIVACAINE; HEPTAKIS(2,6 O DIMETHYL) BETA CYCLODEXTRIN; KLEPTOSE; LIDOCAINE; LOCAL ANESTHETIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; FREEZE DRYING; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; THERMAL ANALYSIS;

EID: 0029867392     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04334-9     Document Type: Article

References (33)

1. Bekers, O., Beijnen, J.H., Groot-Bramel, E.H., Otagaris, M. and Underberg, W.J.M., Effect of cyclodextrins on anthracycline stability in acidic aqueous media. Pharm. Weekbl. (Sci), 10 (1988) 207-212.
2. Bekers, O., Uijtendaal, E.V., Beijnen, J.H., Bult, A. and Underberg W.J.M., Cyclodextrins in the pharmaceutical field. Drug Dev. Ind. Pharm., 17 (1991) 1503-1549.
3. Bellamy, L.J., The infra-red spectra of complex molecules. John Wiley, New York, 1958, p 166.
4. Benumof, J.L., Clinical Procedures in Anaesthesia and Intensive care, J.B. Lippincott, Philadelphia, 1992.
5. Brewster, M.E., Simpkins, J.W., Singhhora, M., Stern, W.C. and Bodor, N., The potential use of cyclodextrins in parenteral formulations. J. Parenter. Sci. Technol., 43 (1989) 231-240.
6. 1H NMR spectroscopy. Magn. Reson. Chem., 26 (1988) 765-774.
7. Duchêne D., Cyclodextrins and their industrial uses, Editions de Santé, Paris, 1987.
8. Duchêne, D. and Wouessidjewe, D., The current state of ß-cyclodextrin in pharmaceutics. Acta Pharm. Technol., 36 (1990a) 1-6.
9. Duchêne, D. and Wouessidjewe, D., Physicochemical characteristics and pharmaceutical uses of cyclodextrin derivatives. Pharm. Technol. Int., June (1990b) 21-29.
10. Erden, N. and Celebi, N., A study of the inclusion complex of naproxen with ß-cyclodextrin. Int. J. Pharm. 48 (1988) 83-89.
11. Fujioka, K., Kurosaki, Y., Sato, S., Noguchi, T., Noguchi, T. and Yamahira, Y., Biopharmaceutical study of inclusion complexes. I. pharmaceutical advantages of cyclodextrin complexes of bencyclane fumarate. Chem. Pharm. Bull., 31 (1983) 2416-2423.
12. Hassan, M.A., Suleiman, M.S. and Najib, N.M., Improvement of the in vitro dissolution characteristics of famotidine by inclusion in ß-cyclodextrin. Int. J. Pharm., 58 (1990) 19-24.
13. Hirayama, F., Hirashima, N., Abe, K., Uekama, K., Ijutsu, T. and Ueno, M., Utilization of diethyl-ß-cyclodextrin as a sustained-release carrier for isosorbide dinitrate. J. Pharm. Sci., 77 (1988) 233-236.
14. Howell, H.B., Major peripheral nerve block. In Benumof, J.L. (Ed.), Clinical Procedures in Anesthesia and Intensive care., J.B. Lippincott, Philadelphia, 1992, pp. 773-786.
15. Irie, T. and Uekama, K., Protection against the photosensitized skin irritancy of chlorpromazine by cyclodextrin complexation. J. Pharmacobiol. Dyn., 8 (1985) 778-791.
16. Jang, J., Yaksh, T.L. and Hill, H.F. Use of 2-hydroxypropyl-ß-cyclodextrin as an intrathecal drug vehicle with opioids. J. Pharmacol. Exp. Ther., 261 (1992) 592-600.
17. Jones, S.P., Grant, D.J.W., Hadgraft, J. and Parr, G.D., Cyclodextrins in the pharmaceutical sciences: preparation, structure and properties of cyclodextrins and cyclodextrin inclusion compounds. Acta Pharm. Technol., 30 (1984) 213-223.
18. Levinson G., Spinal anesthesia. In Benumof, J.L. (Ed.), Clinical Procedures in Anesthesia and Intensive care., J.B. Lippincott, Philadelphia, 1992, pp. 645-662.
19. Lin, S.Y. and Yang, J.C., Inclusion complexation of warfarin with cyclodextrins to improve some pharmaceutical characteristics. Pharm. Weekbl. (Sci.), 8 (1986) 223-228.
20. Meert, T.F., Mesens, J., Verheyen, P. and Noorduin, H., Hydroxypropyl-ß-cyclodextrin can modulate the activity of spinally administered sufentanyl. Eur. J. Anaesthesiol., 9 (1992) 399-409.
21. Müller, B.W. and Brauns, U., Solubilization of drug by modified ß-cyclodextrins. Int. J. Pharm., 26 (1985) 77-88.
22. Otagiri, H., Imai T., Hirayama F. and Uekama K., Inclusion complex formations with cyclodextrins in aqueous solutions and in solid state. Acta Pharm. Suec., 20 (1983) 11-20.
23. Saenger, W., Cyclodextrin inclusion compounds in research and industry. Angew. Chem. Int. Ed. Engl., 19 (1980) 344-362.
24. Stanley, T.H., New routes of administration and new delivery systems of anesthetics. Anaesthesiology, 38 (1988) 665-668.
25. Szejtli, J., Szente, L. and Banky-Elöd, E., Molecular encapsulation of volatile easily oxidizable labile flavour substances by cyclodextrins. Acta. Chim. Acad. Sci. Hung., 101 (1979) 27-46.
26. Szejtli, J., Cyclodextrins and their inclusion complexes, Akademiai Kiado, Budapest, 1982.
27. Szejtli, J., Inclusion Compounds. In Atwood, J.L., Davies, E.D. and MacNiol, D.D. (Eds.), Academic Press, London, 1984.
28. Szejtli, J., The properties and potential uses of cyclodextrin derivatives. J. of Incl. Phenom. and Molec. Recogn. in Chem., 14 (1992) 25-36.
29. Thakkar, A.L. and Demarco, P.V., Cycloheptaamylose inclusion complexes of barbiturates: correlation between proton magnetic resonance and solubility studies, J. Pharm. Sci., 60, (1971) 652-653.
30. Uekama, K., Oh, K., Otagiri, M., Seo, H. and Tsuruoka, M., Improvement of some pharmaceutical properties of clofibrate by cyclodextrin complexation. Pharm. Acta. Helv., 58 (1983) 338-342.
31. Uekama, K. and Irie, T., Pharmaceutical applications of methylated cyclodextrin derivatives. In Duchêne, D. (Ed.), Cyclodextrins and their industrial uses. Editions de Santé, Paris, 1987b, pp 393-439.
32. Van Doorne, H., Bosch, E.H. and Lerk, C.F., Formation and antimicrobial activity of complexes of ß-cyclodextrin and some antimycotic imidazole derivatives. Pharm. Weekbl. (Sci.), 10 (1988) 80-85.
33. Yaksh, T.L., Jang, J., Nishiuchi, Y., Braun, K.P., Ro, S. and Goodman, M., The utility of 2-hydroxypropyl-ß-cyclodextrin as a vehicule for the intracerebral and intrathecal administration of drugs. Life Sci., 48 (1991) 623-633.